MAO-A metabolizes serotonin, a neurotransmitter implicated in depression, while MAO-B catalyzes the oxidation of aminyl substrates, such as dopamine, whose levels are generally diminished in patients with Parkinson’s disease (PD), as result of the progressive degeneration of neurons of the substantia nigra. This evidence concerns the gene MAOA and Parkinson disease.